Compare InVasc Therapeutics vs Lead Therapeutics
Customers evaluate the quality of InVasc Therapeutics's products using the following success metrics.
Overview
InVasc Therapeutics is based in United States
InVasc Therapeutics specializes in target-specific drug discovery and has developed a approach to drug discovery that uses molecular structures and an application-based platform that decreases the time and expense of current large-scale "mining"� discovery techniques. The InVasc process is the result of university-based research at Emory University and The Ohio State University.
Lead Therapeutics is 18 yrs old and is based in United States.
LEAD Therapeutics, Inc. is a chemistry-driven drug discovery company focused on delivering novel and differentiated small molecule pre-IND candidates against clinically validated therapeutic targets by leveraging the best of the US and China. Headquartered in the San Francisco Bay Area, LEAD Therapeutics is led by an experienced small molecule drug discovery team with proven track records in the pharmaceutical and biotech industries. The company plans to carry out the majority of its discovery research activities in China.
Demo Video
Leadership
William D Schaeffer (Chief Executive Officer)
Leonard Post (Founder)
Funding
Investors
Trois I Investments Industriels Internationaux, National Institutes of Health
Pappas Ventures, ProQuest Investments
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because InVasc Therapeutics has not claimed their profile.
Work for InVasc Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for InVasc Therapeutics?
Claim your profile now.
Information not available because Lead Therapeutics has not claimed their profile.
Work for Lead Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Lead Therapeutics?
Claim your profile now.